BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paternostro R, Becker J, Hofer BS, Panagl V, Schiffke H, Simbrunner B, Semmler G, Schwabl P, Scheiner B, Bucsics T, Bauer D, Binter T, Trauner M, Mandorfer M, Reiberger T. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices. Dig Liver Dis 2021:S1590-8658(21)00778-7. [PMID: 34799282 DOI: 10.1016/j.dld.2021.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Giri S. The need of HVPG-guided beta-blocker therapy for NASH cirrhosis with varices - Answer is still up in the air. Dig Liver Dis 2021:S1590-8658(21)00885-9. [PMID: 34916144 DOI: 10.1016/j.dld.2021.11.019] [Reference Citation Analysis]